Page last updated: 2024-08-24

eliprodil and Atherosclerotic Parkinsonism

eliprodil has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brotchie, JM; Hill, MP; Nash, JE	1

Other Studies

1 other study(ies) available for eliprodil and Atherosclerotic Parkinsonism

Article	Year
Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat. Experimental neurology, 1999, Volume: 155, Issue:1 Topics: Animals; Antiparkinson Agents; Binding, Competitive; Corpus Striatum; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reserpine	1999

Article

Year

Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.

Experimental neurology, 1999, Volume: 155, Issue:1

Topics: Animals; Antiparkinson Agents; Binding, Competitive; Corpus Striatum; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reserpine

1999